Avanos Medical (AVNS) Net Cash Flow Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 33.47% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 10.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.99% |
| Dec 31, 2025 | 39.42% |
| Sep 30, 2025 | -51.02% |
| Jun 30, 2025 | -53.26% |
| Mar 31, 2025 | 4.16% |
| Dec 31, 2024 | 1.97% |
| Sep 30, 2024 | -84.20% |
| Jun 30, 2024 | 211.30% |
| Mar 31, 2024 | -5.16% |
| Dec 31, 2023 | 33.77% |
| Sep 30, 2023 | 75.50% |
| Jun 30, 2023 | -33.89% |
| Mar 31, 2023 | -44.08% |
| Dec 31, 2022 | 37.89% |
| Sep 30, 2022 | 29.83% |
| Jun 30, 2022 | 28.02% |
| Mar 31, 2022 | 27.52% |
| Dec 31, 2021 | 41.05% |
| Sep 30, 2021 | 81.12% |
| Jun 30, 2021 | -26.03% |
| Mar 31, 2021 | 22.81% |
| Dec 31, 2020 | -49.69% |
| Sep 30, 2020 | -39.67% |
| Jun 30, 2020 | -35.18% |
| Mar 31, 2020 | -33.94% |
| Dec 31, 2019 | -33.33% |
| Sep 30, 2019 | -125.29% |
| Jun 30, 2019 | 10.68% |
| Mar 31, 2019 | -45.51% |
| Dec 31, 2018 | -52.67% |
| Sep 30, 2018 | -960.00% |
| Jun 30, 2018 | 104.05% |
| Mar 31, 2018 | -45.33% |
| Dec 31, 2017 | -16.55% |
| Sep 30, 2017 | 4.32% |
| Jun 30, 2017 | -3.20% |
| Mar 31, 2017 | 75.58% |
| Dec 31, 2016 | 174.79% |